
IndraLab
Statements
MYSM1 activates translation. 8 / 8
|
8
reach
"Given that prior studies have shown that HSCs have a characteristically low level of protein synthesis and we have demonstrated how reduced protein synthesis due to MYSM1 loss can induce ferroptosis, we wondered if overexpression of MYSM1 could augment protein synthesis in healthy HSCs and thereby protect the cells from ferroptosis."
reach
"Recently, Zhao et al. demonstrated that histone deubiquitinase MYSM1 (Myb-like, SWIRM and MPN domains 1) deficiency reduced the translation of ferroptosis-protective mRNAs, resulting in increased ferroptosis of human hematopoietic stem cells (HSCs), and HSC population maintenance was fully restored by the ferroptosis inhibitors (e.g., deferoxamine (DFO), ferrostatin-1 (Fer-1), and vitamin E)16."
reach
"Overall, we demonstrate that the loss of MYSM1 in mouse B cell lymphoma represses the induction of ribosomal protein genes, reduces cellular protein synthesis rate, promotes p53 activation and potently inhibits cMYC oncogenic functions.To compare the location of the genomic binding sites of MYSM1 and cMYC, we consolidated the ChIP‐Seq datasets for cMYC and its dimerization partner MAX from multipotent haematopoietic progenitor cells HPC7
12
,
13
with the MYSM1 ChIP‐Seq acquired in our recent work in a B cell progenitor cell line Ba/F3."